+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

  • PDF Icon

    Report

  • 110 Pages
  • July 2024
  • Region: Global
  • BCC Research
  • ID: 5987081
This report covers the worldwide market for SNP genotyping, with the market segmented by technology and application. It provides an in-depth analysis of the SNP genotyping market, including estimates and trends through 2029. In this report, the market is divided into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029. This report also uses analytical frameworks such as PESTEL, examines the competitive landscape, and explores trends in ESG and funding.

Report Includes

  • 37 data tables and 44 additional tables
  • An overview of the global market for single nucleotide polymorphism (SNP) genotyping
  • Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projected CAGRs through 2029
  • Evaluation of the current market size and revenue growth prospects specific to SNP genotyping, along with a market share analysis by technology, application, and region
  • Discussion of the advantages of the most frequently used SNP genotyping techniques, such as Sequenom’s MassArray DNA analysis platform, Bruker’s MALDI-TOF array, SNPpyrosequencing, microarrays and gene chips, and Applied Biosystems’ (now part of Thermo Fisher Scientific) SNPlex and TaqMan
  • Analysis of the regulatory framework and policies affecting the industry
  • Discussion of the ESG practices of, as well as challenges for, companies
  • Analysis of the key companies’ market shares and their proprietary technologies, strategic alliances and patents
  • Company profiles of the leading players, including Agilent Technologies Inc., F. Hoffman-La Roche Ltd., Illumina Inc., Qiagen, and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • SNP for Mutational Analysis
  • SNP Definition
  • Methods of Studying SNPs
  • Classification of SNPs
  • PESTEL Analysis
  • Political
  • Economic
  • Social
  • Technological
  • Environmental
  • Legal
Chapter 3 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Declining Prices of DNA Sequencing Methods
  • Demand for Personalized Treatments
  • Personalized Medicine and SNP Genotyping in the Drug Development Process
  • Increasing Demand for Genome Analysis in Plants and Animal Livestock
  • Market Restraints
  • Reimbursement Policies
  • Market Opportunities
  • Increasing Applications of SNP Genotyping
  • Rising Investments in Genomics Research
Chapter 4 Emerging Technologies and Developments
  • SNP-Chip
  • SNP Genotyping Technologies in Forensic Science
  • Artificial Intelligence in SNP Genotyping
Chapter 5 Market Segmentation Analysis
  • Market Trends
  • Segmentation Breakdown
  • Global Market for SNP Genotyping, by Technology
  • Microarrays and GeneChips
  • SNP Pyrosequencing
  • TaqMan Allelic Discrimination
  • Applied Biosystems SNPlex Platform
  • MassArray Maldi-TOF
  • Other SNP Genotyping Technologies
  • Global Market for SNP Genotyping, by Application
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Animal Genetics
  • Plant Improvements
  • Aquaculture
  • Other Applications
  • Geographic Breakdown
  • Global Market for SNP Genotyping, by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Funding
  • Leading Companies
  • Key Strategies Adopted by Players
  • Partnerships
  • Other Strategies
Chapter 7 Sustainability in the SNP Genotyping Market: An ESG Perspective
  • ESG Performance in the Market
  • ESG Practices in the SNP Genotyping Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • ESG Risk Ratings
  • Concluding Remarks
Chapter 8 Appendix
  • Methodology
  • Acronyms
  • References
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
  • BIO-RAD LABORATORIES INC.
  • CYTIVA
  • ENZO BIOCHEM INC.
  • EPIGENDX
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • QIAGEN
  • STANDARD BIOTOOLS
  • THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table: Global Market for SNP Genotyping, by Region, Through 2029
Table 1: SNP Public Databases
Table 2: Role of SNP Genotyping in Stages of the Drug Development Process
Table 3: Global Market for SNP Genotyping, by Technology, Through 2029
Table 4: Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, Through 2029
Table 5: Global Market for Pyrosequencing in SNP Genotyping, by Region, Through 2029
Table 6: Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, Through 2029
Table 7: Global Market for Applied Biosystems SNPlex Platform in SNP Genotyping, by Region, Through 2029
Table 8: Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, Through 2029
Table 9: Global Market for Other Technologies in SNP Genotyping, by Region, Through 2029
Table 10: Global Market for SNP Genotyping, by Application, Through 2029
Table 11: Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, Through 2029
Table 12: Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, Through 2029
Table 13: Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, Through 2029
Table 14: Global Market for Animal Genetics Applications in SNP Genotyping, by Region, Through 2029
Table 15: Global Market for Plant Improvement Applications in SNP Genotyping, by Region, Through 2029
Table 16: Global Market for Aquaculture Applications in SNP Genotyping, by Region, Through 2029
Table 17: Global Market for Other Applications in SNP Genotyping, by Region, Through 2029
Table 18: Global Market for SNP Genotyping, by Region, Through 2029
Table 19: North American Market for SNP Genotyping, by Technology, Through 2029
Table 20: North American Market for SNP Genotyping, by Application, Through 2029
Table 21: National Genome Projects in Europe
Table 22: European Market for SNP Genotyping, by Technology, Through 2029
Table 23: European Market for SNP Genotyping, by Application, Through 2029
Table 24: Asia-Pacific Market for SNP Genotyping, by Technology, Through 2029
Table 25: Asia-Pacific Market for SNP Genotyping, by Application, Through 2029
Table 26: RoW Market for SNP Genotyping, by Technology, Through 2029
Table 27: RoW Market for SNP Genotyping, by Application, Through 2029
Table 28: Major Private and Public Funding Organizations
Table 29: National Human Genome Research Institute, NIH Funded and Completed Projects
Table 30: Leaders in the SNP Genotyping Market, 2023
Table 31: Business Expansions in the Global SNP Genotyping Market, 2021-2024
Table 32: Product Launches in the Global SNP Genotyping Market, 2021-2024
Table 33: Collaborations and Agreements in the Global SNP Genotyping Market, 2022 and 2023
Table 34: Partnerships in the Global SNP Genotyping Market, 2021-2024
Table 35: Other Business Strategies Adopted by Key Players in SNP Genotyping Market, 2021-2024
Table 36: Key Focus Areas in ESG Metrics
Table 37: Environmental Performance Initiatives in the SNP Genotyping Market
Table 38: Social Performance Initiatives in the SNP Genotyping Market
Table 39: Governance Performance Initiatives in the SNP Genotyping Market
Table 40: ESG Rankings for SNP Genotyping Companies, 2023*
Table 41: Abbreviations Used in This Report
Table 42: Agilent Technologies Inc.: Company Snapshot
Table 43: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 44: Agilent Technologies Inc.: Product Portfolio
Table 45: Agilent Technologies Inc.: News/Key Developments, 2021-2023
Table 46: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 47: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 48: Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2021-2023
Table 49: Bio-Rad Laboratories Inc.: Company Snapshot
Table 50: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 51: Bio-Rad Laboratories Inc.: Product Portfolio
Table 52: Cytiva: Company Snapshot
Table 53: Cytiva: Product Portfolio
Table 54: Cytiva: News/Key Developments, 2023
Table 55: Enzo Biochem Inc.: Company Snapshot
Table 56: Enzo Biochem Inc.: Financial Performance, FY 2022 and 2023
Table 57: Enzo Biochem Inc.: Product Portfolio
Table 58: Enzo Biochem Inc.: News/Key Developments, 2022
Table 59: EpigenDx.: Company Snapshot
Table 60: EpigenDx: Service Portfolio
Table 61: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 62: F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 63: F. Hoffman-La Roche Ltd.: Product Portfolio
Table 64: F. Hoffman-La Roche Ltd.: News/Key Developments, 2021
Table 65: Illumina Inc.: Company Snapshot
Table 66: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 67: Illumina Inc.: Services Portfolio
Table 68: Illumina Inc.: News/Key Developments, 2022 and 2023
Table 69: Qiagen: Company Snapshot
Table 70: Qiagen: Financial Performance, FY 2022 and 2023
Table 71: Qiagen: Product Portfolio
Table 72: Qiagen: News/Key Developments, 2023 and 2024
Table 73: Standard BioTools: Company Snapshot
Table 74: Standard BioTools: Financial Performance, FY 2022 and 2023
Table 75: Standard BioTools: Product Portfolio
Table 76: Standard BioTools: News/Key Developments, 2022 and 2023
Table 77: Thermo Fisher Scientific Inc.: Company Snapshot
Table 78: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 79: Thermo Fisher Scientific Inc.: Product Portfolio
Table 80: Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
List of Figures
Summary Figure: Global Market for SNP Genotyping, by Region, 2021-2029
Figure 1: Classification of SNPs
Figure 2: PESTEL Analysis: SNP Genotyping Market
Figure 3: Market Dynamics of SNP Genotyping
Figure 4: Average Cost Per Genome: Y-o-Y Trend, 2011-2022
Figure 5: Snapshot of SNP Genotyping Market: Business Strategies
Figure 6: Global Market Share for SNP Genotyping, by Technology, 2024
Figure 7: Global Market for Microarrays and GeneChips in SNP Genotyping, by Region, 2021-2029
Figure 8: Global Market for Pyrosequencing in SNP Genotyping, by Region, 2021-2029
Figure 9: Global Market for TaqMan Allelic Discrimination in SNP Genotyping, by Region, 2021-2029
Figure 10: Global Market for Applied Biosystems SNPlex in SNP Genotyping, by Region, 2021-2029
Figure 11: Global Market for MassArray Maldi-TOF in SNP Genotyping, by Region, 2021-2029
Figure 12: Global Market for Other Technologies in SNP Genotyping, by Region, 2021-2029
Figure 13: Global Market Share for SNP Genotyping, by Application, 2024
Figure 14: Global Market for Pharmaceuticals and Pharmacogenomics Applications in SNP Genotyping, by Region, 2021-2029
Figure 15: Global Market for Diagnostic Research Applications in SNP Genotyping, by Region, 2021-2029
Figure 16: Major Applications of SNP Genotyping in Agricultural Biotechnology
Figure 17: Global Market for Agricultural Biotechnology Applications in SNP Genotyping, by Region, 2021-2029
Figure 18: Applications of SNP Genotyping in Animal Genetics
Figure 19: Global Market for Animal Genetics Applications in SNP Genotyping, by Region, 2021-2029
Figure 20: Global Market for Plant Improvement Applications in SNP Genotyping, by Region, 2021-2029
Figure 21: Global Market for Aquaculture Applications in SNP Genotyping, by Region, 2021-2029
Figure 22: Global Market for Other Applications in SNP Genotyping, by Region, 2021-2029
Figure 23: Global Market Share for SNP Genotyping, by Region, 2024
Figure 24: Share of New Genetic Tests in the U.S., by CLIA-certified Laboratory, 2012 to 2022
Figure 25: North American Market for SNP Genotyping, by Technology, 2021-2029
Figure 26: North American Market for SNP Genotyping, by Application, 2021-2029
Figure 27: European Market for SNP Genotyping, by Technology, 2021-2029
Figure 28: European Market for SNP Genotyping, by Application, 2021-2029
Figure 29: Drivers of the Asia-Pacific Market for SNP Genotyping
Figure 30: Asia-Pacific Market for SNP Genotyping, by Technology, 2021-2029
Figure 31: Asia-Pacific Market for SNP Genotyping, by Application, 2021-2029
Figure 32: RoW Market for SNP Genotyping, by Technology, 2021-2029
Figure 33: RoW Market for SNP Genotyping, by Application, 2021-2029
Figure 34: Share of the Global SNP Genotyping Market, Competitive Intelligence, by Strategy, 2021-2024
Figure 35: How a Strong ESG Proposition Benefits Businesses
Figure 36: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 37: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 38: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40: Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41: F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42: F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45: Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 46: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 47: Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 48: Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 49: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 50: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

Companies Mentioned

  • Agilent Technologies Inc.
  • Beckman Coulter Inc. (Subsidiary Of Danaher Corp.)
  • Bio-Rad Laboratories Inc.
  • Cytiva
  • Enzo Biochem Inc.
  • Epigendx
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Qiagen
  • Standard Biotools
  • Thermo Fisher Scientific Inc.